Grad School Alumni News

Improving Lives Through Academic Innovation, Commercialization and Entrepreneurship

Harrington and Kappel fireside chat

Why are innovation and entrepreneurship important in academic research? Since the Bayh-Dole Act was passed in 1980, permitting institutions to retain ownership of their inventions arising from federal funding, more than 200 drug treatments and vaccines have been brought to market through academic-commercial partnerships.

Weill Cornell Medicine’s Ninth Annual Dean’s Symposium on Innovation and Entrepreneurship celebrated and fostered this entrepreneurial spirit on Nov. 17 at Weill...

The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug

Hazel Szeto

Jacob Wilson knew something had tangibly changed just six months into a clinical trial evaluating an innovative therapy that targets mitochondria, the energy producing structures inside cells.

...

Five Questions for Wola Osunsade, Ph.D. ’21, Associate Director for Innovation and Transformation at AbbVie

Ph.D student Wola Osunsade

1. What is your current position? 

I am an associate director for innovation and transformation at AbbVie, a biopharmaceutical company headquartered in North Chicago, Illinois.  In many ways, I’m like an in-house consultant. 

2. What does a typical day look like for you? 

I meet with a variety of teams across AbbVie, such as the ones that are running the clinical trials and those that are manufacturing the medicines we make for our patients...

Office of Alumni Relations 1300 York Avenue, Box 61 New York, NY 10065 Phone: 646-962-9560